Status:
UNKNOWN
Predictive Model to Early Diagnosis of Anastomotic Leak After Esophagectomy and Gastrectomy.
Lead Sponsor:
Hospital Universitario La Fe
Conditions:
Esophagus Cancer
Gastric Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
The PROFUGO study (PRedictive Model for the early diagnosis of anastomotic leak after esophagectomy and gastrectomy) is proposed as a prospective and multicenter study at spanish national level that a...
Detailed Description
The methodological properties of the study are described below: 1. \- Type of design Prospective and multicenter study that aims to develop, with the help of artificial intelligence methods, a to...
Eligibility Criteria
Inclusion
- \- Patients with a surgical indication and curative intent due to esophagogastric neoplasia who do not meet exclusion criteria and recruited by hospitals nationwide that decide to participate in the study will be included.
Exclusion
- Patients under 18 or over 85 years
- Patients with chronic infections
- Patients with synchronous tumors in other locations
- Patients with autoimmune disease
- Patients who die in the operating room
- Patients who do not sign the informed consent to participate in the study
- Patients in clinical stage IVB
- Surgical resection R2 (there are macroscopic remains of the tumor in the surgical field after performing the resection of the surgical piece)
- Combined intraoperative resection of other organs
- Surgeries without anastomosis
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05390684
Start Date
May 1 2022
End Date
December 31 2023
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marcos Bruna
Valencia, Spain, 46003